Background and Importance COPD is currently the third leading cause of death worldwide with 3.23 million deaths in 2019. Despite recommendations, many care non-conformities are observed in COPD patients.

Aim and Objectives The aim of the study was to describe the intervention of a clinical pharmacist focused on the respect of COPD management recommendations emitted by the French Health Authority.

Material and Methods Our study is an observational study conducted between January and July 2022. Clinical pharmacist included COPD patients and performed a pharmaceutical interview focused on COPD management. This interview assessed medical follow-up by a pneumologist, smoking, vaccination against pneumococcus, COPD medication, medication adherence and proper use of inhalation devices. The number of non-conformities to recommendations and their distribution were collected at the end of the intervention. Propositions emitted by clinical pharmacist were collected and factors that may have an impact on the recommendations non-compliance were identified.

Results A total of 85 patients were included in the study. The mean age was 70.5 years. A total of 173 non-conformities were detected on 79 patients, i.e., two non-conformities per patient. At least one non-conformity was observed in 93% of patients. The most frequent non-conformities were the misuse of inhalation devices (77.2%) and the absence of vaccination against pneumococcus (67.1%). Follow up by a pneumologist concerned 64.7% of patients, 32.9% of patients were active smokers and 31.2% of the prescriptions were considered to be non-compliant. After interview, 89 propositions were emitted and clinical pharmacist intervention allowed to change COPD medication on 14.1% of patients. Follow-up by a pneumologist increases significantly pneumococcal vaccination coverage and proper use of inhaler devices.

Conclusion and Relevance Our study shows that clinical pharmacist can detect non-conformities and make recommendations to optimise COPD management during patient hospitalisation. This kind of intervention could also be used for patients suffering from other chronic disease as heart failure, asthma or diabetes.

Conflict of Interest No conflict of interest.